全球lactase marketsize is expected to reach USD 289.1 million by 2028 according to a new study by Polaris Market Research.那个报告 ”乳糖酶市场份额，规模，趋势，行业分析报告，由来源（真菌，酵母，细菌）;通过形式（粉末，液体）;通过申请（食品和饮料，{牛奶，奶酪，酸奶，其他}，膳食补充剂，制药）;按地区（北美，欧洲，亚太地区，拉丁美洲，中东和非洲）;分部预测，2021 - 2028“详细了解当前市场动态，并提供未来市场增长分析。
Lactose intolerance (LI) in new-borns is caused due to mutation in the LCT gene, which results in a life-long condition. LI is the rare condition, inherited, most prevalent in Finland. In adults, LI is due to a decrease in the activity of the LCT gene, causing inability in digesting lactose, as they age. It is being assumed that more than 65%of the adult human population has some form of LI, which results in abdominal pain, gastro-intestinal difficulties, after having dairy products.
As per the estimates of the National Institute of Health (NIH), Asian heritage adults are the most common sufferers of lactose intolerance affecting around 70% of the adults and only 5% of the Central and Northern Europeans have lactose intolerance.
Lactase is the enzyme present in the human body, which converts lactose found in dairy products to digestible forms. Rising consumer awareness about eating healthy stuff and the availability of a wide range of lactase-based milk and milk products also positively influencing the market for lactase.
根据2017年的Intermountain Healthcare的已发布的文章，超过65％的成年人具有乳yabo娱乐vip糖酶缺乏，这是一个罕见的疾病，作为个体年龄变得恶化。患有这种缺陷的人，无法在乳制品中存在乳糖，常常有腹泻，胀气和胃腹胀的症状。
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below://m.nkkjrh.com/idustry-analysis/lactase-market/Request-for-sample.
2020年，欧洲乳糖酶市场占全球市场的40％以上。该地区的增长归因于出现良好的食品和乳制品行业，存在关键参与者如Chr。汉森持有和有利的营养和患有乳糖不耐受的人的发病率升高，再加上乳糖酶的膳食补充剂的一次性收入升高，负责该地区的乳糖酶的市场增长。
在乳糖酶市场上运营的公司包括Mitushi Biopharma，Ltd。，杜邦，抗七肉豆生物科技，先进的酶技术，Nemanc Corp.，Aumgene Biosciences，Biolaxi Corp.，Infinita Biotech PVT。，Nature Bioscience PVT。有限公司，创造性酶，阿甘酶Inc.，Merck Kgaa和Novozemes。
yabo官网入口北极星市场研究分段乳糖酶market report on the basis of source, form, application, and region:
Lactase，源前景（收入 - 百万，2016 - 2028）
- Fungi
- Yeast
- 细菌
乳酸酶，形式前景（收入 - 百万，2016 - 2028）
- 粉末
- Liquid
Lactase，Application Outlook（收入 - 百万，2016 - 2028）
- Food & Beverage
- Dietary Supplements
- 药品
Lactase, by Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- U.S.
- 加拿大
- 欧洲
- 法国
- 德国
- UK
- 意大利
- 西班牙
- Netherlands
- Austria
- Asia Pacific
- China
- 印度
- Japan
- 马来西亚
- South Korea
- Indonesia
- Central & South America
- 墨西哥
- 巴西
- 阿根廷
- Middle East & Africa
- UAE
- Saudi Arabia
- 以色列
- South Africa